Changes in Body Mass Index and Atherosclerotic Disease Risk Score After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide

BACKGROUND: Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)-containing antiretroviral therapy (ART) can improve renal function and bone mineral density in people with human immunodeficiency virus (PWH). The switch can also negatively influence cholesterol, but chang...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Open Forum Infect Dis
Prif Awduron: Schafer, Jason J, Sassa, Kaitlin N, O’Connor, Jaclyn R, Shimada, Ayako, Keith, Scott W, DeSimone, Joseph A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2019
Pynciau:
Major Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6786703/
https://ncbi.nlm.nih.gov/pubmed/31660372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz414
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg